Deena Maurer, PhD

Why did you choose the University of Pittsburgh?

I chose Pittsburgh University because of the high levels of collaboration between departments and the access to partake in clinical/translational research. 

Doctoral Dissertation

Dysregulated NF-κB – dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T Cell Responses in Melanoma Patients

Education & Training

  • PhD in Microbiology and Immunology, University of Pittsburgh School of Medicine, 2020
  • MS in Biotechnology, Johns Hopkins University, 2015
  • BS, Marywood University, 2014

Research Interests

Dendritic Cell Biology; Dendritic Cell Vaccines; Immunomonitoring; Translational medicine


Butterfield LH, Vujanovic L, Santos PM, Maurer DM, Gambotto A, Lohr J, Li C, Waldman J, Chandran U, Lin Y, Lin H, Tawbi HA, Tarhini AA and Kirkwood JM. 2019. Multiple Antigen-Engineered DC Vaccines with or without IFNα to Promote Antitumor Immunity in Melanoma. J Immunother Cancer. 7: 113.

Paz H, Tsoi J, Kalbasi A, Grasso CS, McBride WH, Schaue D, Butterfield LH, Maurer DM, Ribas A, Graeber TG and Economou JS. 2019. Interleukin 32 expression in human melanoma. J Transl Med. 17: 113.